Expression of CTLA-4 in nonhuman primate lymphocytes and its use as a potential target for specific immunotoxin-mediated apoptosis: Results of in vitro studies

Clinical and Experimental Immunology

Volumn 135, Issue 2, 2004, Pages 259-266

  Palmisano, G L ^b   Tazzari, P L ^c,e   Cozzi, E ^c,e,f   Bolognesi, A ^d   Polito, L ^d   Seveso, M ^c,e   Ancona, E ^c,e,g   Ricci, F ^c,e   Conte, R ^c,e   Stirpe, F ^d   Ferrara, G B ^a,b   Pistillo, M P ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e University of Padova ^*  (Italy)

^f UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

CTLA 4; Cynomolgus monkeys; Immunotoxins; Tolerance

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOTOXIN; SAPORIN;

ANIMAL CELL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; IMMUNOREACTIVITY; IMMUNOREGULATION; IMMUNOTHERAPY; IN VITRO STUDY; MALE; MAURITIUS; MONKEY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHILIPPINES; PRIORITY JOURNAL; RNA ANALYSIS; RNA TRANSCRIPTION; TRANSPLANTATION TOLERANCE;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; APOPTOSIS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; IMMUNE TOLERANCE; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTOXINS; LEUKOCYTES, MONONUCLEAR; MACACA FASCICULARIS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; T-LYMPHOCYTES; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 10744224222     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2003.02382.x     Document Type: Article

References (33)

1. Lambrigts D, Sachs DH, Cooper DK. Discordant organ xenotransplantation in primates: world experience and current status. Transplantation 1998; 66:547-61.
2. Platt JL, Vercellotti GM, Dalmasso AP et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11:450-6.
3. Teranishi K, Manez R, Awwad M, Cooper DK. Anti-Gal alpha 1-3Gal IgM and IgG antibody levels in sera of human and old world non-human primates. Xenotransplantation 2002; 9:148-54.
4. Sandrin MS, Vaughan HA, Dabkowski PL, McKenzie IF. Anti-pig IgM antibodies in human serum react predominantly with Gal (alpha 1-3) Gal epitopes. Proc Natl Acad Sci USA 1993; 90:11391-5.
5. Alwayn IP, Basker M, Buhler L, Cooper DK. The problem of anti-pig antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of anti-pig antibodies. Xenotransplantation 1999; 6:157-68.
6. Galili U, Matta KL. Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides. Transplantation 1996; 62:256-62.
7. Alwayn IP, Xu Y, Basker M et al. Effects of specific anti-B and/or antiplasma cell immunotherapy on antibody production in baboons: depletion of CD20-and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Xenotransplantation 2001; 8:157-71.
8. Phelps CJ, Koike C, Vaught TD et al. Production of alpha 1,3-galactosyltransferase-deficient pigs. Science 2003; 299:411-4.
9. Lindeborg E, Kumagai-Braesch M, Tibell A, Moller E. Continued production of xenoimmune antibodies 6-8 years after clinical transplantation of fetal pig islet-like cell-clusters. Xenotransplantation 2001; 8:273-83.
10. Richards AC, Davies HF, McLaughlin ML et al. Serum anti-pig antibodies as potential indicators of acute humoral xenograft rejection in pig-to-cynomolgus monkey kidney transplantation. Transplantation 2002; 73:881-9.
11. Buhler L, Awwad M, Basker M et al. High-dose porcine hematopoietic cell transplantation combined with CD40 ligand blockade in baboons prevents an induced anti-pig humoral response. Transplantation 2000; 69:2296-304.
12. Walunas TL, Lenschow DJ, Bakker CY et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1994; 1:405-13.
13. Krummel MF, Allison JP. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J Exp Med 1995; 182:459-65.
14. Pistillo MP, Tazzari PL, Ellis JH, Ferrara GB. Molecular characterization and applications of recombinant scFv antibodies to CD152 costimulatory molecule. Tissue Antigens 2000; 55:229-38.
15. Pistillo MP, Tazzari PL, Stirpe F et al. Anti-CTLA-4 human scFv antibodies could prevent T cell activation in transplantation. Transplant Proc 2001; 33:285-7.
16. Tazzari PL, Polito L, Bolognesi A et al. Immunotoxins containing recombinant anti-CTLA-4 single-chain fragment variable antibodies and saporin: in vitro results and in vivo effects in an acute rejection model. J Immunol 2001; 167:4222-9.
17. Barbieri L, Bolognesi A, Valbonesi P, Polito L, Olivieri F, Stirpe F. Polynucleotide adenosine glycosidase activity of immunotoxins containing ribosome-inactivating proteins. J Drug Target 2000; 8:281-8.
18. Villinger F, Bostik P, Mayne A et al. Cloning, sequencing, and homology analysis of nonhuman primate Fas/Fas-ligand and co-stimulatory molecules. Immunogenetics 2001; 53:315-28.
19. Holmes BJ, Richards AC, Awwad M et al. Anti-pig antibody levels in naive baboons and cynomolgus monkeys. Xenotransplantation 2002; 9:135-47.
20. Pistillo MP, Tazzari PL, Bonifazi F et al. Detection of a novel specificity (CTLA-4) in ATG/TMG globulins and sera from ATG-treated leukemic patients. Transplantation 2002; 73:1295-302.
21. Cozzi E, Bhatti F, Schmoeckel M et al. Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation 2000; 70:15-21.
22. Taylor CJ, Tang KG, Smith SI, White DJ, Davies HF. HLA-specific antibodies in highly sensitized patients can cause a positive crossmatch against pig lymphocytes. Transplantation 1998; 65:1634-41.
23. Pistillo MP, Tazzari PL, Palmisano GL et al. CTLA-4 is not restricted to the lymphoid cell lineage and can function as a target molecule for apoptosis induction of leukemic cells. Blood 2003; 101:202-9.
24. Magistrelli G, Jeannin P, Herbault N et al. A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells. Eur J Immunol 1999; 29:3596-602.
25. Sachdeva G, Patil V, Katkam RR et al. Expression profiles of endometrial leukemia inhibitory factor, trasforming growth factor β2 (TGFβ2), and TGFβ2 receptor in infertile bonnet monkeys. Biol Reprod 2001; 65:1-8.
26. Freeman GJ, Lombard DB, Gimmi CD et al. CTLA-4 and CD28 mRNA are coexpressed in most T cells after activation. Expression of CTLA-4 and CD28 mRNA does not correlate with the pattern of lymphokine production. J Immunol 1992; 149:3795-801.
27. Armstrong N, Buckley P, Oberley T et al. Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. Transplantation 1998; 66:5-13.
28. Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M. Mechanisms of transplant tolerance induction using costimulatory blockade. Rev Curr Opin Immunol 2002; 14:592-600.
29. Kirk AD, Harlan DM, Armstrong NN et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci USA 1997; 94:8789-94.
30. Kirk AD, Burkly LC, Batty DS et al. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med 1999; 5:686-93.
31. Remou F, Rogerie F, Gallissot MC et al. Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations. J Infect Dis 2000; 181:1855-9.
32. Vine MF, Stein L, Weigle K. Gender differences in response to the multitest CMI skin test in the general population. Ann Allergy Asthma Immunol 2000; 84:445-50.
33. Levings MK, Sangregorio R, Sartirana C et al. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1T regulatory cells. J Exp Med 2002; 196:1335-46.